CLAL Biotechnology Industries Ltd. Logo

CLAL Biotechnology Industries Ltd.

A life sciences VC firm financing and supporting innovative biotech & healthcare ventures.

CBI | TA

Overview

Corporate Details

ISIN(s):
IL0011042806
LEI:
Country:
Israel
Address:
Triangle Building 45th flr., 67023 Tel Aviv
Sector:
Financial and insurance activities
Industry:
Other financial service activities, except insurance and pension funding activities

Description

Clal Biotechnology Industries Ltd. (CBI) is a leading life sciences investment company and venture capital firm founded in 1998. CBI specializes in identifying, financing, and supporting innovative ventures within the biotechnology and healthcare sectors. Its investment strategy focuses on biopharmaceutical, diagnostic, and medical device companies that develop proprietary solutions to address significant unmet medical needs with high market potential. The firm actively manages its portfolio companies, providing strategic support to foster their growth from early-stage development through to commercialization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-08 10:01
Investor Presentation
Corporate Presentation, January 2023
English 3.1 MB
2023-01-08 10:01
Regulatory News Service
Corporate Presentation, January 2023
Russian 41.8 KB
2021-02-14 15:58
Investor Presentation
CBI-Presentation-February 2021
English 2.4 MB
2021-02-14 15:58
Pre-Annual General Meeting Information
CBI-Presentation-February 2021
Russian 43.2 KB
2020-11-22 11:19
Investor Presentation
INVESTORS PRESENTATION,NOVEMBER 10,2020
English 1.9 MB
2020-11-22 11:19
Post-Annual General Meeting Information
INVESTORS PRESENTATION,NOVEMBER 10,2020
Russian 43.3 KB
2020-08-24 11:54
Investor Presentation
CORPORATE PRESENTATION AUGUST 2020
English 1.7 MB
2020-08-24 11:54
Regulatory News Service
CORPORATE PRESENTATION AUGUST 2020
Russian 43.2 KB

Automate Your Workflow. Get a real-time feed of all CLAL Biotechnology Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CLAL Biotechnology Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Compagnie des Tramways de Rouen Logo
A holding company focused on securities portfolio management and liquidity investment.
France MLTRA
Conferize A/S Logo
Former event tech platform provider transitioning to an investment firm focused on AI.
Denmark CONFRZ
Corporacion Financiera Alba S.A. Logo
Investment firm taking long-term minority stakes in leading companies via PE, VC, and real estate.
Spain ALB
COSMOS YATIRIM HOLDİNG A.Ş. Logo
An investment holding firm financing high-potential businesses for sustainable, strategic growth.
Türkiye COSMO
CRAVEN HOUSE CAPITAL PLC Logo
Invests own capital in high-growth companies in frontier and developing markets.
United Kingdom CRV
Creades Logo
Invests in and develops small/medium listed and unlisted Nordic companies for long-term value.
Sweden CRED
Crowdfundme Logo
Italian crowdinvesting platform for startups, SMEs, and real estate projects.
Italy CFM
Crown Energy AB Logo
Investment firm transitioning from energy to focus on medtech, greentech, and real estate.
Sweden CRWEN
Crypto-Blockchain Industries SA Logo
Invests in digital assets and develops blockchain games and its proprietary metaverse.
France ALCBI
Cube Labs S.p.A. Logo
Venture builder creating healthcare startups by commercializing scientific R&D in life sciences.
Italy CUBE

Talk to a Data Expert

Have a question? We'll get back to you promptly.